| Literature DB >> 12747806 |
Serge Carreau1, Sophie Lambard, Christelle Delalande, Isabelle Denis-Galeraud, Barbara Bilinska, Sonia Bourguiba.
Abstract
The ability of the testis to convert irreversibly androgens into estrogens is related to the presence of a microsomal enzymatic complex named aromatase, which is composed of a specific glycoprotein, the cytochrome P450 aromatase (P450arom) and an ubiquitous reductase. The aromatase gene is unique in humans and contained 18 exons, 9 of them being translated. In the rat testis we have immunolocalized the P450arom not only in Leydig cells but also in germ cells and especially in elongated spermatids. Related to the stage of germ cell maturation, we have shown that the level of P450arom mRNA transcripts decreases, it is much more abundant in pachytene spermatocytes and round spermatids than in mature germ cells whereas the aromatase activity is 2-4 fold greater in spermatozoa when compared to the younger germ cells. Using a highly specific quantitative competitive RT-PCR method we have evidenced that several factors direct the expression of the aromatase gene in Leydig cells, Sertoli cells, pachytene spermatocytes and round spermatids, and it is obvious that promoter PII is the main one but other promoters could be concerned. In the bank-vole testis we have observed a positive correlation between a fully developed spermatogenesis and a strong immunoreactivity for both P450arom and estrogen receptor beta not only in Sertoli cells but also in pachytene spermatocytes and round spermatids. Our recent data obtained from ejaculated human spermatozoa demonstrate the presence of aromatase both in terms of mRNA and protein, and in addition, we suggest that aromatase could be involved in the acquisition of sperm motility. Indeed in men the congenital aromatase deficiency is associated with severe bone maturation problems and sterility. Together with the widespread distribution of estrogen receptors in testicular cells these data clearly show that estrogens play a physiological role in the regulation of spermatogenesis in mammals.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12747806 PMCID: PMC155680 DOI: 10.1186/1477-7827-1-35
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Aromatase deficiencies in men
| Authors | Affected Exon | Mutation |
| Morishima et al., 1995* | IX | Arg375Cys |
| Carani et al., 1997 | IX | Arg365Gln |
| Deladoey et al., 1999* | V | Leu157XΔC-stop |
| Maffei et al., 2001* | V | Nucleotide 628 G to A Insertion of 10aa and stop |
| Kottler et al., 2002 | IX | Insertion of T position 1058 and stop |
| Herrmann et al., 2002 | V | C to A substitution position 3 and stop |
* see Carani et al [44] for details
Figure 1Aromatase and estrogen receptors (ER) in adult male rat gonad. PS: pachytene spermatocytes, RS: round spermatids, Spz: spermatozoa. Aromatase has been demonstrated in terms of mRNA (RT-PCR), protein (Western blots) and enzyme activity (measurements of estradiol output in culture media) in the various testicular cells. ER : estrogen receptors localisation.
Figure 2Human spermatozoa : source and targets of estrogens. It has been shown that human ejaculated spermatozoa contain aromatase as revealed by the mRNA, protein on Western blots and the presence of endogenous estradiol. As far as estrogen receptors are concerned mainly ER alpha are present.